Event Specialty: Bronchoscopy
Lecture
Sunday, May 20 from 1:00 - 1:30 pm
Thomas Gildea, MD
Pulmonary Medicine
The Monarch Platform was designed to help physicians diagnose, and eventually treat, hard-to-reach, small peripheral nodules with greater precision than ever before.
The Monarch Platform received U.S. Food and Drug Administration (FDA) clearance in March 2018 for diagnostic and therapeutic bronchoscopic procedures. The platform integrates the latest advancements in robotics, software, data science, and endoscope innovation. It uses a familiar controller interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with improved reach, vision, and control.
Hosted from May 18 – May 23, the American Thoracic Society's International Conference brings in nearly 14,000 pulmonary, critical care, and sleep professionals, all looking to learn the latest advancements in their respective fields from colleagues around the world.
Bronchoscopy:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.